Overview

A Trial to Evaluate the Efficacy and Safety of Methoxyetomidate Hydrochloride for Injection (ET-26) for the Induction of General Anesthesia in Elective Surgery Subjects

Status:
RECRUITING
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, etomidate-controlled phase III clinical trial. The primary objective is to compare the efficacy and safety between ET-26 and etomidate in the induction of general anesthesia in subjects undergoing elective surgery, so as to provide a reference for the marketing registration of methoetomidate hydrochloride for injection.
Phase:
PHASE3
Details
Lead Sponsor:
Ahon Pharmaceutical Co., Ltd.